Effect of central obesity, low high-density lipoprotein cholesterol and C-reactive protein polymorphisms on C-reactive protein levels during treatment with Rosuvastatin (10 mg Daily).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples